Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
Although biomarkers are perceived as highly relevant for future clinical practice, few biomarkers reach clinical utility for several reasons. Among them, poor reporting of studies is one of the major problems. To aid improvement, reporting guidelines like REMARK for tumour marker prognostic (TMP) st...
Hlavní autoři: | Sekula, P, Mallett, S, Altman, D, Sauerbrei, W |
---|---|
Médium: | Journal article |
Vydáno: |
Public Library of Science
2017
|
Podobné jednotky
-
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles.
Autor: Peggy Sekula, a další
Vydáno: (2017-01-01) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
Autor: Mallett, S, a další
Vydáno: (2010) -
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines.
Autor: Mallett, S, a další
Vydáno: (2010) -
REporting recommendations for tumour MARKer prognostic studies (REMARK).
Autor: McShane, L, a další
Vydáno: (2005) -
Reporting recommendations for tumor marker prognostic studies (REMARK).
Autor: McShane, L, a další
Vydáno: (2005)